OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 122 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $32,452,000 | -28.3% | 18,868 | -12.0% | 0.00% | – |
| Q3 2015 | $45,249,000 | -61.1% | 21,445 | -8.8% | 0.00% | – |
| Q2 2015 | $116,384,000 | -35.1% | 23,512 | +2.7% | 0.00% | – |
| Q1 2015 | $179,252,000 | +136.6% | 22,893 | +83.1% | 0.00% | – |
| Q4 2014 | $75,750,000 | -75.0% | 12,500 | -82.4% | 0.00% | – |
| Q3 2014 | $303,223,000 | +82.6% | 71,179 | +166.6% | 0.00% | – |
| Q2 2014 | $166,047,000 | -63.1% | 26,694 | -64.3% | 0.00% | – |
| Q1 2014 | $449,439,000 | +6406.1% | 74,707 | +5988.6% | 0.00% | – |
| Q4 2013 | $6,908,000 | -95.6% | 1,227 | -95.3% | 0.00% | – |
| Q3 2013 | $158,418,000 | -20.5% | 25,843 | -24.1% | 0.00% | – |
| Q2 2013 | $199,239,000 | – | 34,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |